|
|
|
|
| 2 Emerging Biotech Companies That Continue to Attract Attention (more) | 2011 05 23
|
|
| Phase 3 Trial of Genasense(R) in Advanced Melanoma Does Not Show Significan (more) | 2011 05 23
|
|
| Isis Pharmaceuticals to Present a General Corporate Update at Its 2011 Annu (more) | 2011 05 23
|
|
| Alnylam to Webcast Presentation at ThinkEquity's 2nd Annual Health Care Con (more) | 2011 05 20
|
|
|
| The Medicines Company Engages in Stent for Life Initiative in Europe (more) | 2011 05 20
|
|
|
|
|
| Progenics Announces Results of Methylnaltrexone Phase 3 Safety Study in Chr (more) | 2011 05 20
|
|
|
| Dendreon Announces Webcast Presentation at Upcoming Conferences (more) | 2011 05 20
|
|
|
| Onyx Pharmaceuticals Announces Updated Pivotal Carfilzomib Phase 2B Data (more) | 2011 05 19
|
|
|
| NPS Pharmaceuticals to Present at ThinkEquity Healthcare Conference (more) | 2011 05 19
|
|
|
|
| Isis Initiates Phase 1 Study of ISIS-TTRRx and Earns $5 Million Milestone P (more) | 2011 05 19
|
|
|
|
| AVI BioPharma to Present Company Overview at the ThinkEquity 2nd Annual Hea (more) | 2011 05 19
|
|
| Alnylam's ALN-VSP Abstract Published by American Society of Clinical Oncolo (more) | 2011 05 19
|
|
|
|
| Nexavar in Combination with Chemotherapy Improves Progression-Free Survival (more) | 2011 05 18
|
|
|
| Dendreon Announces Presentation of PROVENGE Data at the 2011 American Socie (more) | 2011 05 18
|
|
| Oncothyreon's Run Indicates the Stock Is Rising Above the Radar (more) | 2011 05 18
|
|
| Dendreon Announces Clinical Trial Plans for PROVENGE and DN24-02 at the Ame (more) | 2011 05 18
|
|
| BioMarin to Present at the UBS Global Specialty Pharmaceuticals Conference (more) | 2011 05 18
|
|
|
| Regulus Therapeutics Expands Executive Team with Recent Appointments (more) | 2011 05 18
|
|
|
| Nexavar Data to Be Presented at American Society of Clinical Oncology Annua (more) | 2011 05 18
|
|
| Onyx Pharmaceuticals Announces Data Presentations of Carfilzomib and ONX 09 (more) | 2011 05 18
|
|
| Regulus Therapeutics Expands Executive Team with Recent Appointments (more) | 2011 05 18
|
|
|
|
| Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders (more) | 2011 05 17
|
|
| AVI BioPharma Issued Broad Composition of Matter Patent for PMOplus(TM) Che (more) | 2011 05 17
|
|
| Genta Announces Clinical Presentations on Lead Compounds, Tesetaxel and Gen (more) | 2011 05 17
|
|
| Avanir Pharmaceuticals to Present Data at the American Psychiatric Associat (more) | 2011 05 17
|
|
|
|
|
|
| Genta Incorporated Reports First Quarter 2011 Corporate Highlights and Fina (more) | 2011 05 16
|
|
|
|
|
|
| Isis Earns $3 Million Payment as Collaboration With GSK Expands (more) | 2011 05 16
|
|
|
|
| Critical Alerts For IBM, MGM Resorts, Coach, McDermott International, and O (more) | 2011 05 14
|
|
|
|
|
|
|
|
|
|
| Are Avanir's Sub-Par Sales for New Drug an Early Sign of a Dud? (more) | 2011 05 11
|
|
|
|
|
|
|
|
|
|
| Rebound Ideas: 7 Oversold Stocks With Sufficient Cash to Cover Operating Ex (more) | 2011 05 10
|
|
|
| Nabi Biopharmaceuticals to Present at Noble Financial's Seventh Annual Equi (more) | 2011 05 10
|
|
| Isis Pharmaceuticals' and GSK's Innovative Collaboration Voted Breakthrough (more) | 2011 05 10
|
|
| The Zacks Analyst Blog Highlights: Dean Foods, Isis Pharmaceuticals, OncoGe (more) | 2011 05 10
|
|
| Progenics Pharmaceuticals Announces First Quarter 2011 Financial Results (more) | 2011 05 10
|
|
|
|
|
|
|
| GATTEX® (teduglutide) Shown to Reduce Parenteral Support Volume in Patient (more) | 2011 05 10
|
|
|
|
|
| JDRF and Amylin Partner to Investigate Co-Formulating Two Hormones for Trea (more) | 2011 05 10
|
|
| Avanir Pharmaceuticals' CEO Discusses F2Q11 Results - Earnings Call Transcr (more) | 2011 05 10
|
|
|
|
| MannKind's CEO Discusses Q1 2011 Results - Earnings Call Transcript (more) | 2011 05 09
|
|
|
|
|
| MannKind Corporation Reports 2011 First Quarter Financial Results (more) | 2011 05 09
|
|
|
